Cutaneous Cancer

Melanoma:

CIRB #H-41279/ CTSU #EA6191 (PET-stop): A Phase II Study of Biomarker Driven Early Discontinuation of Anti-PD-1 Therapy in Patients with Advanced Melanoma (PET-Stop)

Kaposi Sarcoma:

CIRB #H-42705/ AMC #108: Multicenter Phase II Study of Pomalidomide Monotherapy in Kaposi Sarcoma

Metastatic/Advanced 2nd+ Line Solid Tumors:

KRAS/NRAS/HRAS/BRAF positive
CIRB #H-42956/ ETCTN #10449: A Phase 1 Study of ZEN003694 in Combination with Binimetinib in Solid Tumors with RAS Pathway Alterations and Triple Negative Breast Cancer (temporary closure)